The mission of The DOLF Project is to develop and test improved treatments for onchocerciasis and lymphatic filariasis that will enhance efforts to control and eliminate these important neglected tropical diseases.


DOLF Team Supports New Clinical Trial in Cote d’Ivoire

The DOLF Team Supports a New Clinical Trial in Côte d’Ivoire to Test Safety of Moxidectin in Regions co-Endemic to Onchocerciasis and Lymphatic Filiariasis Onchocerciasis (oncho), also known as river blindness, is a serious, debilitating, and stigmatizing parasitic disease. It is a major neglected tropical disease that causes severe skin disease and blindness in more […]

A New DOLF Publication Highlights Promising New Results in Support of Onchocerciasis Elimination

Onchocerciasis (“river blindness”), a parasitic disease that leads to debilitating and stigmatizing ailments, has been targeted by the World Health Organization for elimination. New drug treatments that kill or permanently sterilize female worms could accelerate this process. The DOLF team, together with our partners at the University of Health and Allied Sciences (UHAS) in Ghana […]

The DOLF Team’s 2022: Year in Review

As we look towards a new year, we wanted to share some highlights from 2022, a year that saw many new advances and developments in our research on Lymphatic Filariasis (LF) and Onchocerciasis (Oncho). LF research Cote d’Ivoire. In late winter, DOLF team members traveled to Côte d’Ivoire for 12-month follow-up visits for patients enrolled […]
  • Cote d'Ivoire